During an in-person Community Case Forum event in Miami, Florida, Mike Cusnir, MD, discussed the ARANOTE study outcomes ...

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.

They initially lost 40 pounds effortlessly, but now the weight is returning and so are the craving for sweets.

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...

Introduction Acute exacerbation of interstitial lung disease (AE-ILD) often results in death and poses significant challenges ...

Accurate interpretation of electrolyte blood results is key to patient diagnosis and management. Read our guide.

Data from lowest dose level cohorts demonstrate a favorable safety and efficacy profile Data includes complete results from ...

Detailed price information for Fortress Biotech Inc (FBIO-Q) from The Globe and Mail including charting and trades.

Detailed price information for Atyr Pharma Inc (ATYR-Q) from The Globe and Mail including charting and trades.